Article

Urology Times BPA Statement, July 2005

Newsletter

Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.

Subscribe Now!
Related Videos
Nicolette G. Payne, MD, answers a question during a Zoom video interview
Nicolette G. Payne, MD, discusses the rise in burnout among pediatric urologists
Alicia Morgans, MD, highlights the phase 3 ARASTEP trial
Alicia Morgans, MD, highlights the phase 3 ARASTEP trial
Kevin T. McVary, MD, FACS, answers a question during a Zoom video interview
Kevin T. McVary, MD, FACS, discusses the expanded label for Rezum in BPH
Ongoing Investigations: Expanding the Role of Cretostimogene in NMIBC Care
Ongoing Investigations: Expanding the Role of Cretostimogene in NMIBC Care
Diving Deeper: Discussing Results From Cohort C in the BOND-003 Trial
Diving Deeper: Discussing Results From Cohort C in the BOND-003 Trial
Amy Krambeck, MD, on considerations for building clinical programs in endourology
Amy Krambeck, MD, on considerations for building clinical programs in endourology
Ruben Olivares, MD, answers a question during a Zoom video interview
Ruben Olivares, MD, discusses HIFU and remote prostate cancer care
Mitchell Huang, MD, on the cost-effectiveness of transperineal vs transrectal prostate biopsy
Mitchell Huang, MD, on the cost-effectiveness of transperineal vs transrectal prostate biopsy
David Stanley, MD, on current trends in the management of kidney stones
David Stanley, MD, on current trends in the management of kidney stones
Alicia Morgans, MD, on QOL outcomes with darolutamide plus ADT in mHSPC
Alicia Morgans, MD, on QOL outcomes with darolutamide plus ADT in mHSPC
Related Content
Use of surgical therapy for erectile dysfunction remains low, study shows
June 27th 2025

Use of surgical therapy for erectile dysfunction remains low, study shows

Hannah Clarke
The study also found racial differences in the time to proceeding with surgical therapy.
Pearls & Perspectives: Sexual Health in MSM, with Joshua R. Gonzalez, MD
June 19th 2025

Pearls & Perspectives: Sexual Health in MSM, with Joshua R. Gonzalez, MD

Amy M. Pearlman, MD
The conversation covers practical, case-based strategies for counseling MSM patients.
Colorful DNA molecule. Concept image of a structure of the genetic code. | Image Credit: © ktsdesign - stock.adobe.com
June 26th 2025

Genomic test can predict resistance to chemotherapy in prostate cancer

Hannah Clarke
The test utilizes chromosomal instability signatures to predict resistance to taxane-based chemotherapy in metastatic prostate cancer.
Pearls & Perspectives: Understanding and Improving Pelvic Health, with Diane Newman, DNP
June 2nd 2025

Pearls & Perspectives: Understanding and Improving Pelvic Health, with Diane Newman, DNP

Amy M. Pearlman, MD
Phase 3 data of oral sulopenem for uUTIs published in NEJM Evidence
June 25th 2025

Phase 3 data of oral sulopenem for uUTIs published in NEJM Evidence

Hannah Clarke
Oral sulopenem was approved by the FDA in October 2024 for the management of uUTIs.
FDA grants RMAT designation to detalimogene voraplasmid for high-risk NMIBC
June 25th 2025

FDA grants RMAT designation to detalimogene voraplasmid for high-risk NMIBC

Hannah Clarke
Detalimogene is currently under evaluation in the pivotal phase 1/2 LEGEND trial.
© 2025 MJH Life Sciences

All rights reserved.